Cas no 28978-02-1 (Pectolinarin)
Pectolinarin Chemical and Physical Properties
Names and Identifiers
-
- Pectolinarin
- 5-Hydroxy-6-methoxy-2-(4-methoxyphenyl)-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-
- Parishin A
- 5-hydroxy-6-methoxy-2-(4-methoxyphenyl)
- Neolinarin
- pectolinarigenin 7-O-rutinoside
- PECTOLINARIN(P)
- Pectolinaroside
- 5,7-Dihydroxy 4′,6-dimethoxyflavone 7-rutinoside
- 7-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one
- Pectolinarigenin 7-rutinoside
- CID 134728117
- [ "" ]
- 5,7-Dihydroxy 4',6-dimethoxyflavone 7-rutinoside
- 142925-51-7
-
- MDL： MFCD12546128
- Inchi： 1S/C29H34O15/c1-11-20(31)23(34)25(36)28(41-11)40-10-18-21(32)24(35)26(37)29(44-18)43-17-9-16-19(22(33)27(17)39-3)14(30)8-15(42-16)12-4-6-13(38-2)7-5-12/h4-9,11,18,20-21,23-26,28-29,31-37H,10H2,1-3H3/t11-,18+,20-,21+,23+,24-,25+,26+,28+,29+/m1/s1
- InChI Key： DUXQKCCELUKXOE-WCNMBJSRSA-N
- SMILES： O1[C@@]([H])([C@]([H])([C@@]([H])([C@]([H])([C@]1([H])C([H])([H])O[C@]1([H])[C@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])[H])O1)O[H])O[H])O[H])O[H])O[H])O[H])OC1C([H])=C2C(C(C([H])=C(C3C([H])=C([H])C(=C([H])C=3[H])OC([H])([H])[H])O2)=O)=C(C=1OC([H])([H])[H])O[H]
Computed Properties
- Exact Mass: 622.19000
- Monoisotopic Mass: 622.19
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 7
- Hydrogen Bond Acceptor Count: 15
- Heavy Atom Count: 44
- Rotatable Bond Count: 8
- Complexity: 1000
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 9
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 223
- Molecular Weight: 622.6
- XLogP3: -0.5
Experimental Properties
- Color/Form: Yellow powder
- Density: 1.61
- Boiling Point: 896.4°Cat760mmHg
- Flash Point: 292.4°C
- Refractive Index: 1.682
- PSA: 227.20000
- LogP: -0.78670
- Vapor Pressure: 0.0±0.3 mmHg at 25°C
Pectolinarin Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement：
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Hazardous Material transportation number：NONH for all modes of transport
- Safety Instruction： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition：2-8°C
Pectolinarin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| S e l l e c k ZHONG GUO | S9054-1mg |
Pectolinarin |
28978-02-1 | 99.93% | 1mg |
￥876.73 | 2023-09-15 | |
| HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI | BZP0412-20mg |
Pectolinarin |
28978-02-1 | HPLC≥98% | 20mg |
￥1050元 | 2023-09-15 | |
| ChemFaces | CFN99727-20mg |
Pectolinarin |
28978-02-1 | >=98% | 20mg |
$118 | 2021-07-22 | |
| SHANG HAI YUAN YE Biotechnology Co., Ltd. | B20249-20mg |
Pectolinarin |
28978-02-1 | ,HPLC≥98% | 20mg |
￥600.00 | 2021-09-02 | |
| ChemScence | CS-0008812-5mg |
Pectolinarin |
28978-02-1 | 99.89% | 5mg |
$50.0 | 2022-04-27 | |
| ChemScence | CS-0008812-10mg |
Pectolinarin |
28978-02-1 | 99.89% | 10mg |
$80.0 | 2022-04-27 | |
| ChemScence | CS-0008812-20mg |
Pectolinarin |
28978-02-1 | 99.89% | 20mg |
$140.0 | 2022-04-27 | |
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | SMB00344-10MG |
Pectolinarin |
28978-02-1 | 10mg |
￥2671.68 | 2023-09-14 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | SMB00344-50MG |
Pectolinarin |
28978-02-1 | 50mg |
￥8633.09 | 2023-09-14 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | PHL82622-10MG |
Pectolinarin |
28978-02-1 | 10mg |
￥5051.31 | 2023-09-09 |
Pectolinarin Suppliers
Audited Supplier
Audited Supplier
Pectolinarin Related Literature
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
Additional information on Pectolinarin
Pectolinarin (CAS No. 28978-02-1): A Comprehensive Overview
Pectolinarin (CAS No. 28978-02-1) is a naturally occurring flavone glycoside that has garnered significant attention in the fields of medicinal chemistry and pharmacology due to its diverse biological activities. This compound, primarily found in plants of the Asteraceae family, such as Centaurea solstitialis and Echinops ritro, has been the subject of numerous studies exploring its potential therapeutic applications.
The chemical structure of Pectolinarin is characterized by a flavone backbone with specific glycosidic substitutions, which contribute to its unique pharmacological properties. Recent advancements in analytical techniques have enabled a more detailed understanding of its molecular structure and interactions, facilitating its use in various research and development projects.
In the realm of medicinal chemistry, Pectolinarin has shown promising results in several areas. One of the most notable is its anti-inflammatory activity. Studies have demonstrated that Pectolinarin can effectively inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, making it a potential candidate for the treatment of inflammatory diseases like arthritis and inflammatory bowel disease (IBD).
Additionally, Pectolinarin has been investigated for its antioxidant properties. Research has shown that it can scavenge free radicals and protect cells from oxidative damage, which is crucial in preventing a wide range of diseases, including cardiovascular disorders and neurodegenerative conditions. These findings have sparked interest in developing Pectolinarin-based formulations for use in dietary supplements and functional foods.
The antitumor effects of Pectolinarin have also been a focus of recent studies. Preclinical research has indicated that this compound can induce apoptosis in cancer cells and inhibit tumor growth by modulating various signaling pathways. For instance, it has been shown to downregulate the expression of Bcl-2, an anti-apoptotic protein, and upregulate the expression of Bax, a pro-apoptotic protein. These mechanisms make Pectolinarin a promising candidate for cancer therapy, particularly in combination with other chemotherapeutic agents.
Beyond its therapeutic potential, Pectolinarin has also been explored for its role in plant defense mechanisms. As a secondary metabolite, it plays a crucial role in protecting plants from herbivores and pathogens by acting as a natural deterrent. This property has led to investigations into its use in agricultural applications, such as developing biopesticides that are environmentally friendly and sustainable.
The safety profile of Pectolinarin is another important aspect that has been extensively studied. Toxicological evaluations have generally shown that it is well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.
In conclusion, Pectolinarin (CAS No. 28978-02-1) is a multifaceted compound with significant potential in various therapeutic areas. Its anti-inflammatory, antioxidant, and antitumor properties make it an attractive candidate for further research and development. As ongoing studies continue to unravel its mechanisms of action and optimize its delivery methods, the future prospects for this natural product are promising.
